Results 271 to 280 of about 592,213 (353)
Some of the next articles are maybe not open access.

Spiro Benzodiazepine Substituted Fluorocoumarins as Potent Anti-Anxiety Agents

Russian Journal of Bioorganic Chemistry, 2021
1,5-Benzodiazepines are one of the important class of tranquilizers. The fusion of heterocyclic systems like coumarins and indolines with the benzodiazepine seems quite encouraging for the synthesis of derivatives with enhanced anti-anxiety property. The benzodiazepine derivatives containing fluorine were synthesized and studied for their anti-anxiety ...
Dayanand Patagar   +6 more
openaire   +2 more sources

A simple and reliable conflict procedure for testing anti-anxiety agents

Psychopharmacologia, 1971
The effects of three benzodiazepines (chlordiazepoxide, diazepam, and oxazepam), meprobamate, pentobarbital, d-amphetamine sulfate, magnesium pemoline, and scopolamine hydrobromide were studied with a simple conflict procedure in which thirsty naive rats were periodically administered shocks for licking water.
J R, Vogel, B, Beer, D E, Clody
openaire   +3 more sources

Anti-anxiety agents: a pharmacoepidemiological review

Human Psychopharmacology: Clinical and Experimental, 1999
The purpose of this review is to broaden the base for informed policy and to identify research issues to improve the utility of anti-anxiety agents. Data quality is discussed and the prevalence of morbid anxiety and the exposure to treatment with, and abuse of, anti-anxiety agents in different populations is presented.
C. Allgulander
openaire   +2 more sources

Anti-anxiety agents: duration of use and characteristics of users in the U.S.A.

Current Medical Research and Opinion, 1984
A national survey of psychotherapeutic drug use was carried out in the U.S.A. in 1979. Data were obtained from a probability sample (n = 3161) of adults in the general population, using a clinically-oriented interview lasting an average of 90 minutes.
G D, Mellinger   +2 more
openaire   +3 more sources

Chapter 3 Anti-Anxiety Agents, Anticonvulsants, and Sedative-Hypnotics

open access: closed, 1979
Publisher Summary This chapter summarizes the nature of the benzodiazepine receptor that has been characterized further, by the demonstration that a single class of binding sites exists in rat brain for a structurally diverse series of benzodiazepines.
Joel G. Berger, Louis C. Iorio
openalex   +2 more sources

Chapter 1. Antipsychotic and Anti-anxiety Agents

1969
Publisher Summary This chapter discusses results of studies focusing on antipsychotic and antianxiety agents. Studies revealed that medazepam alleviates anxiety and tension in children and adults with minimal sedative side effect and without impairment of working capacity or normal alertness.
Irwin J. Pachter, Alan A. Rubin
openaire   +2 more sources

Chapter 2. Anti-Anxiety Agents, Anticonvulsants, and Sedative-Hypnotics

open access: closed, 1982
Publisher Summary This chapter discusses the biochemical mechanisms of action of anxiolytics, anticonvulsants and sedatives, and to a better understanding of the causes and nature of the disorders for which they are used. Strong evidence continues to support a functional link between benzodiazepines (BZ), gamma-aminobutyric acid (GABA), and chloride ...
RichardC. Effland
openalex   +2 more sources

Sedatives and anti-anxiety agents in critical illness

open access: closed, 2016
Abstract Sedative and anti-anxiety agents are administered to many mechanically-ventilated intensive care unit (ICU) patients. While commonly considered supportive care, suboptimal administration of sedatives has been linked to longer duration of mechanical ventilation and longer ICU length of stay.
Curtis N. Sessler, Katie M. Muzevich
openalex   +2 more sources

Chapter 1. Antipsychotic and Anti-anxiety Agents

open access: closed, 1971
Publisher Summary This chapter discusses the results of studies focusing on antipsychotic and anti-anxiety agents. A double blind controlled study showed an approximately 10% better response in schizophrenic patients with droperidol than with haloperidol.
R. Ian Fryer
openalex   +2 more sources

Ondansetron: A Novel Anti-anxiety Agent

open access: closed, 1991
Although the widely used benzodiazepines for control of anxiety have met with high patient acceptance, there is a hesitation about long-term use owing to the possibility of dependence. The new azaspirodecanedione compounds such as buspirone (Buspar) are free from dependence but raise the spectre of tardive dyskinesia since they are derivatives of the ...
F.S. Abuzzahab
openalex   +2 more sources

Home - About - Disclaimer - Privacy